Position in XENE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,077,099
+$3,226,913 QoQ
Shares Held
862,775
+2.7% QoQ
Ownership
0.891%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital World Investors holds $27,435,334,973 across 33 Biotechnology names. XENE ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,115,014 | $12,972,110,904 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,144,846 | $3,354,932,991 | |
| 3 | ARGX |
Argenx SE
|
2,199,770 | $2,040,880,612 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
21,669,226 | $1,718,152,929 | |
| 5 | MRNA |
Moderna, Inc.
|
22,276,996 | $1,560,058,029 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,008,244 | $750,663,936 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,697,610 | $650,043,081 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
2,249,582 | $641,063,382 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,077,099 | 862,775 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $48,850,186 | 840,072 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $29,390,132 | 655,737 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $26,327,840 | 655,737 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,524,568 | 655,737 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $74,639,188 | 2,224,715 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $89,945,850 | 2,294,537 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $105,572,111 | 2,681,537 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $104,553,127 | 2,681,537 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $115,440,167 | 2,681,537 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $123,511,594 | 2,681,537 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $77,713,111 | 2,274,974 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $87,586,499 | 2,274,974 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $81,421,319 | 2,274,974 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $89,702,224 | 2,274,974 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $82,126,561 | 2,274,974 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $69,204,709 | 2,274,974 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $69,545,955 | 2,274,974 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $71,070,187 | 2,274,974 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,722,280 | 963,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,940,370 | 963,500 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,246,650 | 963,500 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $14,818,630 | 963,500 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,665,945 | 963,500 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $12,082,290 | 963,500 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,926,090 | 963,500 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||